Ascent Wealth Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.62M Buy
13,143
+663
+5% +$236K 0.54% 58
2025
Q4
$4.08M Buy
12,480
+4,205
+51% +$1.33M 0.47% 58
2025
Q3
$2.34M Sell
8,275
-737
-8% -$214K 0.27% 74
2025
Q2
$2.52M Sell
9,012
-106
-1% -$30K 0.31% 67
2025
Q1
$2.84M Buy
9,118
+94
+1% +$27.8K 0.38% 60
2024
Q4
$2.35M Buy
9,024
+64
+0.7% +$19K 0.32% 62
2024
Q3
$2.89M Sell
8,960
-33
-0.4% -$10.8K 0.4% 58
2024
Q2
$2.81M Buy
8,993
+164
+2% +$48.2K 0.41% 55
2024
Q1
$2.43M Buy
8,829
+5,088
+136% +$1.49M 0.36% 59
2023
Q4
$1.08M Buy
3,741
+120
+3% +$32.7K 0.18% 96
2023
Q3
$973K Buy
+3,621
New +$904K 0.18% 97

Other funds holding AMGN

Ascent Wealth Partners's AMGN Position: Q1 2026 in Review

Ascent Wealth Partners increased its Amgen (AMGN) stake by 5.3% in Q1 2026, buying an estimated $236K and bringing the position to 13,143 shares worth $4.62M. The position accounts for 0.54% of the portfolio, ranked #58.

Ascent Wealth Partners first reported a position in AMGN in Q3 2023 and has held it in 11 quarters since. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Ascent Wealth Partners held 13,143 shares of Amgen worth $4.62M as of Q1 2026.
  • Ascent Wealth Partners bought 663 Amgen shares in Q1 2026, an estimated $236K.
  • Amgen made up 0.54% of Ascent Wealth Partners's portfolio in Q1 2026, its #58 holding.
  • Ascent Wealth Partners first reported a position in Amgen in Q3 2023 and has held it in 11 quarters since.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Ascent Wealth Partners's 13F filing for Q1 2026, filed 6 May 2026.